I posed the other day that Neuren was not "Hot", hence the relatively depressed SP.
After reading the quarterly, I wonder whether the fact that Neuren cannot progress 2591 for any indications that Acadia pursues with Daybue is causing people to question the value. It seems very open ended and could mean that Acadia could commence a P1 trial for Daybue in any indication just to snooker Neuren.
Could be completely wrong but I wonder whether that plays a part.
Ann: Q2 2023 quarterly activity and cash flow report, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.26 |
Change
-0.280(2.23%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $6.952M | 570.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 231 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.32 | 1979 | 2 |
View Market Depth
| Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |